BioCentury
ARTICLE | Clinical News

Mifepristone: Interim Phase I/II data

June 29, 2015 7:00 AM UTC

Interim data from 13 patients with metastatic breast cancer in the Phase I portion of an open-label, dose-escalation U.S. Phase I/II trial showed that once-daily oral mifepristone plus Halaven eribul...